The size of the connected health device market, which was US$ 13.2 billion in 2016, is expected to grow at an annual rate of 3 percent over the next decade.
Connected health devices are now involved in each step of the treatment process, from the initial diagnosis through to the monitoring of vital signs. Patients can now use these new products to monitor their health all on their own.
These new trends reflect the desires of patients, who no longer wish to be simple observers in their treatment process. Pacemakers and insulin pumps are perfect examples.
Pharmaceutical companies are very keen on these new technologies, as they enable them to obtain health data about a population nearly in real time, eliminating the need for specialized studies.